Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15286850 | 0.85 | SIGMAR1 (0.48) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL3297380 | 0.75 | TAAR1 (0.50) | TAAR1LOXL2MAOB | |
| SCHEMBL17596168 | 0.75 | — | — | |
| Benzene SCHEMBL3440179 | 0.73 | ALDH1A1 (0.69) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL9741303 | 0.73 | ALDH1A1 (0.69) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL62125 | 0.73 | ALDH1A1 (0.69) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| Bromide SCHEMBL3519090 | 0.72 | TSHR (0.48) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL25402413 | 0.70 | ALDH1A1 (0.65) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| Hydrogen Sulfide SCHEMBL5468201 | 0.70 | ALDH1A1 (0.65) | TDP1ALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL3759913 | 0.70 | ALDH1A1 (0.65) | TDP1ALDH1A1HPGDALOX15ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| US-12600707-B2 | Cannabinoid derivatives, precursors and uses | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2026-04-14 | — | — | US | disclosed |
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| US-20250205232-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250059152-A1 | CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS | KARE CHEMICAL TECH INC (CA) | 2025-02-20 | — | — | US | disclosed |
| US-12168009-B2 | Modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-12-17 | — | — | US | disclosed |
| US-20240174627-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2024-05-30 | — | — | US | disclosed |
| EP-4305027-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | Kare Chemical Technologies Inc. (CA) | 2024-01-17 | — | — | EP | disclosed |
| US-20230233560-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-07-27 | — | — | US | disclosed |
| WO-2023102655-A1 | CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2023-06-15 | — | — | WO | disclosed |
| WO-2007048802-A1 | (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-03 | — | — | WO | disclosed |
| US-7109339-B2 | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-09-19 | — | — | US | disclosed |
| US-20060189636-A1 | Inhibitors of E1 activating enzymes | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| WO-2006084281-A1 | INHIBITORS OF E1 ACTIVATING ENZYMES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-08-10 | — | — | WO | disclosed |
| EP-1682510-A2 | METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION | Wyeth (US) | 2006-07-26 | — | — | EP | disclosed |
| EP-1581221-A2 | SUBSTITUTED TRICYCLIC GAMMA-CARBOLINES AS SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2005047258-A2 | METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION | WYETH (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050101569-A1 | Methods and compositions for selectin inhibition | WYETH (US) | 2005-05-12 | — | — | US | disclosed |
| US-20040180875-A1 | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2004-09-16 | — | — | US | disclosed |
| WO-2004056324-A2 | SUBSTITUTED TRICYCLIC GAMMA-CARBOLINES AS SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059152-A1 | CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS | CNR2, CNR1, CES2 | TDP1 1027/4885ALDH1A1 2191/4885HPGD 289/4885 |
| US-20240174627-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | CNR2, CNR1, SQLE | TDP1 2421/4885ALDH1A1 3156/4885HPGD 474/4885 |
| US-12600707-B2 | Cannabinoid derivatives, precursors and uses | CNR1, CNR2, GPR18 | TDP1 3707/4885ALDH1A1 3776/4885HPGD 914/4885 |
| US-20250205232-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1B, SLC26A4 | TDP1 4837/4885ALDH1A1 3524/4885HPGD 1850/4885 |
| US-20230233560-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1B, SLC26A4 | TDP1 4837/4885ALDH1A1 3524/4885HPGD 1850/4885 |
| US-20040180875-A1 | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists | HTR1A, HTR7, HTR5A | TDP1 3739/4885ALDH1A1 1837/4885HPGD 4054/4885 |
| US-20050101569-A1 | Methods and compositions for selectin inhibition | SELP, SELE, SELL | TDP1 4223/4885ALDH1A1 285/4885HPGD 411/4885 |
| US-12168009-B2 | Modulators of cystic fibrosis transmembrane conductance regulator | CFTR, SCNN1B, SLC26A4 | TDP1 4837/4885ALDH1A1 3524/4885HPGD 1850/4885 |
| US-20060189636-A1 | Inhibitors of E1 activating enzymes | ECE1, RNASE1, RCE1 | TDP1 344/4885ALDH1A1 987/4885HPGD 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.